Effect of anti-TB drugs on immune antibodies development

TB poses significant challenges to developing economies as it primarily affects people during their most productive years. Although, the therapeutic regimens for TB are extremely effective, studies have shown that undesirable drug interactions can occur. If the adverse reactions are severe, it may contribute to changes in the therapeutic regimen, substantially increasing treatment costs, as well as the number of home visits, outpatient visits, hospitalizations and patients interrupting or abandoning treatment resulting in higher rates of treatment failure and acquired resistance, as well as an increase in the number of tuberculosis cases and, more rarely, in the number of deaths. Some patients can make IgG blood group antibodies if the patients are on long term medications. Immune antibodies can potentially destroy own platelets with resultant spontaneous bleeding and also owns red cells as in autoimmune haemolytic anaemia (AIHA), or it can cause haemolytic transfusion reaction (HTR), haemolytic disease of the foetus and newborn (HDFN) in pregnant women. This little book showed the effect of anti-TB drugs on immune antibodies development.